The Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyps
NCT05131464 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 46
Last updated 2024-11-08
Summary
This is an open-label, single-arm, multicenter, extension study to evaluate the long-term safety and efficacy of CM310 in patients with CRSwNP.
Conditions
Interventions
- DRUG
-
CM310
CM310, 300 mg/2 mL, SC, every 2 weeks
Sponsors & Collaborators
-
Keymed Biosciences Co.Ltd
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-11-30
- Primary Completion
- 2024-01-31
- Completion
- 2024-01-31
Countries
- China
Study Locations
More Related Trials
-
A Study to Evaluate 611 in Patients With Chronic Rhinosinusitis With Nasal Polyps
NCT06639295 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study of CM512 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （NEZHA-1）
NCT06930612 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of SHR-1905 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps
NCT05891483 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
CST1-Guided Oral Glucocorticoids Management for CRSwNP
NCT05598411 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Anti-IL-5 Therapy With Simple Polypectomy Versus Extended Endoscopic Sinus Surgery for CRSwNP
NCT07200336 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps
NCT07132827 ·Status: RECRUITING ·Phase: PHASE3
-
Dupilumab in Chinese Adult Participants With CRSwNP
NCT05878093 ·Status: COMPLETED ·Phase: PHASE3
-
Study on Biomarkers to Predict the Efficacy of IL-4R Monoclonal Antibody for Chronic Rhino-sinusitis With Polyps
NCT05428410 ·Status: UNKNOWN
-
A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
NCT07313917 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps
NCT06691113 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Nasal Microbiota Transfer Therapy in Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)
NCT05400616 ·Status: RECRUITING ·Phase: NA
-
A Extension Clinical Study of TQC2731 Injection in the Treatment of Chronic Sinusitis With Nasal Polyps
NCT06451640 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of HTMC0658 Tablets in the Treatment of Chronic Rhinosinusitis Without Nasal Polyps
NCT07174115 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS)
NCT04607005 ·Status: COMPLETED ·Phase: PHASE3
-
An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps
NCT03478930 ·Status: COMPLETED ·Phase: PHASE3
-
Tapering of Biologics in Chronic Rhinosinusitis With Nasal Polyps
NCT07187583 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of GR1802 in Participants With Chronic Sinusitis With Nasal Polyps
NCT06516302 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
The Study of GR1802 in Patients with Chronic Rhinosinusitis with Nasal Polyps
NCT05873803 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps
NCT07107256 ·Status: RECRUITING ·Phase: PHASE3
-
Etokimab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
NCT03614923 ·Status: COMPLETED ·Phase: PHASE2
-
A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps
NCT06801353 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps
NCT05274750 ·Status: COMPLETED ·Phase: PHASE3
-
The Study of Long-term Outcomes of GR1802 in Patients With Chronic Rhinosinusitis With Nasal Polyps
NCT06015243 ·Status: UNKNOWN ·Phase: PHASE2
-
GB001 in Adult Participants With Chronic Rhinosinusitis
NCT03956862 ·Status: COMPLETED ·Phase: PHASE2
-
CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps
NCT05598424 ·Status: RECRUITING ·Phase: PHASE4